• Home
  • About Risky Finance
  • Nick Dunbar
    • The Devil’s Derivatives
    • Inventing Money
    • About Nick Dunbar
  • Follow us
subscribe
Login
Menu
  • Visualisation tools
    • Currencies
    • Corporate bonds
    • UK Local government
    • Asset Management
    • Sovereign
    • Banking
    • Equities
    • Inflation
  • Articles
    • Stocks
    • Pensions
    • Banks
    • Credit
    • Technology
    • Economics
    • Municipal Finance
    • Funds
  • Reviews & research
    • Book Reviews
Homestem cells

The stem cell challenge

19 October 2010Articleslongevity risk, medicine, science, stem cellsNick Dunbar

Last weekend, I attended a lecture given by Douglas Melton, the director of Harvard University's Stem Cell Institute. Stem cells are the medical equivalent of the philosophers' stone, especially those in human embryos which spontaneously differentiate themselves into heart, brain, liver and other cells that make up the body. The stem cells we possess as…

Continue reading..

Join our mailing list

  • Recent Articles
  • Recent Charts
  • How Japan is changing, in...
    Japan's financial markets are undergoing profound ...
  • Playing MSCI’s quarterl...
    Every quarter, MSCI's index rebalancing announceme...
  • How the S&P 500 moved int...
    Two new visualisations show how AI transformed the...
  • iBoxx top movers
  • EU bank corporate loan exposure by country
  • Interest rate benchmark rigging fines & prosecutions
  • Quarterly R&D expense for companies with AI activity
  • Central bank bond holdings as a percentage of outstanding debt
  • Most Viewed
  • Most Commented
  • The $3 trillion hidden exposure behind the Archegos blowup

  • Lost Lobos

  • House of Debt

  • How the S&P 500 moved into hyperspace

  • Advances in Financial Machine Learning

  • How JP Morgan broke the repo market
  • How Covid-19 infected the corporate bond market
  • Deutsche Bank and the Big Short
  • Giants of the S&P500
  • Nature Bites Back In New, Messy World of Derivatives

  • Contact
  • Help
  • Contribute
  • Terms & Conditions

Copyright © 2026, Risky Finance . All rights reserved.